IWC
ALXO icon

Integrated Wealth Concepts’s ALX Oncology ALXO Stock Holding History

Integrated Wealth Concepts’s Portfolio ALXO Stock Details ALXO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$270 Buy
+130
New +$233 ﹤0.01% 5723

Other funds holding ALXO

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
VP
venBio Partners San Francisco, California $519M AUM 339.42% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $32.9B AUM 23.66% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $962M AUM 524.64% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return

Integrated Wealth Concepts's ALXO Position: Q2 2026 in Review

Integrated Wealth Concepts opened a new position in ALX Oncology (ALXO) in Q2 2026: 130 shares worth $270. The stake represents ﹤0.01% of the portfolio and ranks #5723 among its holdings.

94 funds tracked by Wall St. Rank hold ALXO as of Q2 2026.

  • Integrated Wealth Concepts held 130 shares of ALX Oncology worth $270 as of Q2 2026.
  • ALX Oncology was a new Integrated Wealth Concepts position in Q2 2026.
  • ALX Oncology made up ﹤0.01% of Integrated Wealth Concepts's portfolio in Q2 2026, its #5723 holding.
  • 94 funds tracked by Wall St. Rank held ALX Oncology as of Q2 2026.

Based on Integrated Wealth Concepts's 13F filing for Q2 2026, filed 12 Aug 2026.